Why Subscribers Massively Overestimate the Benefits of Conventional Cancer Treatments and Underestimate Natural Treatments

Executive Summary

  • Subscribers treating cancer frequently make two inaccurate estimations – one is overestimating the effectiveness of conventional treatments. The second is underestimating the effectiveness of natural treatments.

Introduction

This article is based on my interactions with many subscribers on the topic of how to prevent and treat cancer.

The Overestimation of the Effectiveness of Conventional Cancer Treatments

One thing that stands out to me is subscribers’ overestimation of the effectiveness of conventional cancer treatments. What surprised me is that those who subscribe to the website tend to be significantly more skeptical of the medical establishment than the general population. However, even though the articles on the effectiveness of all of the conventional treatments are available right from the Article Index, even still — I often find that subscribers will only read parts of the articles related to cancer and will skip the articles that cover the effectiveness of the treatment they are undergoing! I will say that subscribers who have already experienced conventional treatments are usually much more willing to read and accept the articles than those currently undergoing traditional cancer treatment.

The foundational assumption of the great majority of the public is that if a medical treatment, and any medical treatment — is offered by hospitals, that must mean that both the medicine must be effective and that there has been a sophisticated cost/benefit analysis performed to ensure that the treatment continues to be used. Neither of these assumptions is true. The vast majority of new chemotherapy drugs, for example, do nothing to extend life (although they do shrink tumors) –and the costs for chemotherapy drugs are incredibly high. If a cost/benefit analysis were performed, virtually all chemotherapy drugs would not pass such a test. Yet, every year large numbers of new chemotherapy drugs are approved. What does that tell you?